This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The pharmaceutical industry has been up in arms over Medicare’s first list of 10 prescription drugs that will be subject to negotiations. But other major parts of the health care industry — hospitals, doctors, and other providers — have refrained from either lending support or criticizing the government’s process.
For several years , some of the world’s largest pharmaceuticalcompanies that participate in a U.S. drug discount program overcharged the federal government and numerous hospitals by hundreds of millions of dollars, according to claims made in a recently unsealed lawsuit. and their number has grown over the years.
Federal lawmakers investigating the Steward Health Care bankruptcy moved on Thursday to compel testimony from chief executive Ralph de la Torre about his role in the hospital system’s financial collapse.
The genetic data, cross-referenced with the patients’ de-identified medical records, will be available for purchase for researchers and life sciences companies. Pharmaceuticalcompany Regeneron has invested $119.5
More than a decade ago, Ken Mandl was on a call with a pharmaceuticalcompany and the leader of a social network for people with diabetes. The drug maker was hoping to use the platform to encourage its members to get a certain lab test. The test could determine a patient’s need for a helpful drug.
Belgian anti-trust regulators are probing Roche over concerns that the drug company took steps to delay the entry of biosimilar versions of two of its cancer medicines. The agency also maintained Roche disseminated “erroneous information” about using biosimilars in combination therapy.
In a setback to the pharmaceutical industry, a U.S. appeals court has upheld an Arkansas law that allows hospitals participating in a controversial federal discount program to ship medicines to certain pharmacies. There are roughly 12,400 hospitals and clinics that participate across the U.S.
Novartis has filed a lawsuit seeking to block a Maryland law that requires the company to ship its medicines to any pharmacy working with hospitals participating in a controversial U.S. government drug discount program. Continue to STAT+ to read the full story…
The massive sum spent by AbbVie, the maker of the mega blockbuster anti-inflammatory drug Humira, is the most a pharmaceuticalcompany has spent on marketing to doctors since such data became available in 2017.
government agency warned Sanofi that it faces sanctions over plans to change the way payments are made to most hospitals participating in a drug discount program, the third time in recent months that a major pharmaceuticalcompany has been threatened with such a step. Continue to STAT+ to read the full story…
In a bid to blunt competition and address rising drug costs, Sanofi is offering a warranty that will cover the cost for any hospital if a specific medicine fails to work, marking only the second time a major pharmaceuticalcompany has taken such a step.
AstraZeneca filed a lawsuit seeking to block an Arkansas law that requires the company to ship its medicines to any pharmacy working with hospitals participating in a controversial federal discount program. The move comes less than a month after a U.S. The move comes less than a month after a U.S.
The heads of pharmaceuticalcompanies and medical device firms continued to sit at the top as their patented products reaped the biggest windfalls. Those figures compared to an average of $13 million and median of $4.3 million in 2022. Continue to STAT+ to read the full story…
The rules would apply broadly across the economy, but they have strong implications for the health care industry, where sizable deals among hospitals, physician practices, private equity firms, health insurers, pharmacy benefit managers, pharmaceuticalcompanies, medical device firms, and numerous other entities occur almost weekly.
The massive sum spent by the company, which makes the blockbuster Humira anti-inflammatory drug, is the most a pharmaceuticalcompany has doled out on marketing to doctors since such data became available in 2017. Continue to STAT+ to read the full story…
A company being built from the ashes of IBM’s Watson Health division is launching new lines of business with a much different message: The real value is in the health data, not the fancy AI engine it might eventually power. Continue to STAT+ to read the full story…
Multinational drug and medical device makers are grappling with narrower profit margins in China, largely due to the country’s system of having companies bid to supply drugs and devices to public hospitals — known as volume-based procurement. Continue to STAT+ to read the full story…
Pharmaceuticalcompanies have long been driven by global demand and the potential for the highest profits. The move could act as a proof of concept for bringing drugs to UK patients that pharmaceuticalcompanies aren’t willing to risk their profits on. That fact can hardly be contested.
Approval of this drug system for this indication is supported by positive clinical results demonstrating rapid improvement in depressive symptoms compared to placebo, according to the pharmaceuticalcompany. At week 4, 22.5 percent of patients taking SPRAVATO achieved remission. This was compared to 7.6
Orchid Pharma, a Chennai-based pharmaceuticalcompany catering across the pharmaceutical value chain (discovery to delivery) with expertise in R&D and marketing, has announced the appointment of Chief Executive Officer (CEO), Rajnish Rohatgi.
Tero Silvola is CEO and board member of BC Platforms, and owner of Riverpark Oy, an investment and development company co-operating with five IT and healthcare start-ups. Emanuel Timor, general partner, Vertex Ventures has more than 20 years of experience working with start-up companies and emerging businesses.
RwHealth , the leading provider of Artificial Intelligence to the healthcare industry, has today reported 160 per cent year-on-year growth as its data-led solutions are increasingly embraced by NHS trusts, private healthcare providers and major pharmaceuticalcompanies.
Abid Rahman from Intouch Group tells pharmaphorum how AI-based technology is solving challenges across healthcare systems, pharmaceuticalcompanies, and patient treatment. We can put AI use cases in three buckets – healthcare and hospital systems, pharmaceuticalcompanies and patient and caregivers.”.
Prior to Medicaid rebates, manufacturers would routinely offer substantially lower prices to these hospitals, but the rebate formula required manufacturers to provide a rebate equal to the greater of a fixed percentage of average manufacturer price or the “best price” offered to non-exempt entities.
Pharmaceuticalcompanies face unique challenges due to their rapid digital transformation, adopting Internet of Things (IoT), Artificial Intelligence (AI), and blockchain technologies. The Indian pharmaceutical industry, vital for both domestic and global healthcare, relies heavily on data to drive its operations. With over 1.9
Sensyne Health has signed a five-year non-exclusive Strategic Research Agreement (SRA) with Milton Keynes University Hospital NHS Foundation Trust (MKUH). MKUH will take an equity stake in Sensyne Health and receive 1,428,571 ordinary shares in the UK company, representing 1.1% The dataset covers 650,000 unique patient records.
The Janssen PharmaceuticalCompanies of Johnson & Johnson has revealed that according to new safety data, SPRAVATO ® (esketamine nasal spray [NS]) has demonstrated superior efficacy compared to quetiapine extended-release (Quetiapine XR) for treatment-resistant depression (TRD).
According to a report by The American Hospital Association , the number of Americans with chronic medical conditions will grow by a projected 9% between 2020 and 2030, an increase of 14 million people. Moreover, it’s estimated that nearly 90% of all large hospitals are already operating their own specialty pharmacies.
According to a report by The American Hospital Association , the number of Americans with chronic medical conditions will grow by a projected 9% between 2020 and 2030, an increase of 14 million people. Moreover, it’s estimated that nearly 90% of all large hospitals are already operating their own specialty pharmacies.
Chandru Chawla, a pharma veteran writes an open letter to those CEOs of Pharmaceuticalcompanies who have NOT purchased Electoral Bonds and have NOT made political donations through other means Dear Pharma CEO who did NOT make political donations Compliments from an ordinary soon-to-be senior citizen and a consumer of medicines.
Better management of customer data could help pharmaceuticalcompanies’ digital transformation, according to Veeva’s Rebecca Silver. She pointed to the Veeva European Customer Reference Data Survey that showed 41% of companies are not satisfied with the quality of their third-party legacy providers of customer data.
Dr Eric Hughes joins Teva with experience in all phases of drug development at global pharmaceuticalcompanies, most recently Boston-based Vertex Pharmaceuticals, which he joined last year. He will be based out of Teva’s US headquarters in Parsippany, New Jersey. . Dr Hughes earned his MD and PhD at Yale School of Medicine.
[pharmaceuticalcompanies] must take measures to manage antibiotic waste across the manufacturing supply chain” 2023 has so far, delivered a spectrum of change for antibiotic manufacturers across the pharmaceutical industry, from supply chain issues through to regulatory opportunities.
According to a report by The American Hospital Association , the number of Americans with chronic medical conditions will grow by a projected 9% between 2020 and 2030, an increase of 14 million people. Moreover, it’s estimated that nearly 90% of all large hospitals are already operating their own specialty pharmacies.
In the same statement, Pfizer also announced it has signed a pledge by the US Department of Health and Human Services (HHS) that calls on US healthcare system stakeholders such as hospitals, health systems, payers, suppliers and pharmaceuticalcompanies to reduce GHG emissions and build a more climate resilient healthcare infrastructure.
CASE STUDY Negotiating Bulk Orders with Hospitals A Strategic Partnership Approach Table of Contents Case Study Characters: John (Sales Director, XYZ Pharma): Leading the negotiation on behalf of XYZ Pharma, John is a seasoned sales professional with extensive experience in the pharmaceutical industry. John: Good morning, Sarah.
CASE STUDY Negotiating Bulk Orders with Hospitals A Strategic Partnership Approach Table of Contents Case Study Characters: John (Sales Director, XYZ Pharma): Leading the negotiation on behalf of XYZ Pharma, John is a seasoned sales professional with extensive experience in the pharmaceutical industry. John: Good morning, Sarah.
The task of mitigating costs associated with corporate hospitals and asserting our professional identity presents itself as an imperative.” Presently, over 50% of prescriptions issued by physicians are for fixed dosage combinations spanning various therapeutic categories.
With COVID-19 anticipated to change how pharmaceuticalcompanies engage with healthcare professionals, Ipsen UK&I is preparing for a more remote and virtual healthcare system. Prior to the pandemic, 95% of all the company’s UK customer facing teams’ interactions took place in person at NHS hospitals.
GlobalData’s analysis also uncovers the companies at the forefront of each innovation area and assesses the potential reach and impact of their patenting activity across different applications and geographies.
Pharmaceuticalcompanies often struggle to actively involve patients in the design phase of clinical trials but doing so can have huge benefits for the sustainability and success of research. In 2014 Keith was fortunate to become a full-time salaried patient research ambassador at Liverpool Heart and Chest Hospital Trust.
Health systems could look into this technology to spot patients who may need intervention prior to an exacerbation and ER/Hospital admission, while Pharma could use this data in their clinical studies. 3M Intelligent Control Inhaler - New comer to the field, 3M is still looking to partner with a pharmaceuticalcompany to use its device.
With more data and leads available to your pharmaceuticalcompany, exponential growth and scalability quickly become a reality. Electronic Medical Record, or EMR, are digital versions of the paper charts in clinician offices, clinics, and hospitals. An inside sales rep can work faster and cover more ground every day.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content